The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study
Open accessAbstract
Anal cancer is a rare cancer but its incidence is increasing. Human papillomavirus (HPV) infection seems to be associated with the occurrence of most cases. The genotype‐specific prevalence of HPV in anal cancer was estimated to assess the potential benefit of HPV vaccination in France. Anal cancer histological specimens were retrospectively recruited in 2008 from 16 French centres and centrally tested for HPV genotyping using the INNO‐LiPA assay allowing the detection of 28 genotypes. Results were analyzed according to age, gender, HIV status when available and histological diagnosis. A total of 366 anal cancer cases were analyzed among which 62% were females. Mean age at diagnosis was 54.8 years in males and 66.4 years in females (p < 0.001). HPV was found in 96.7% of cases, 72% being infected by a single HPV type. Presence of at least one high‐risk genotype was observed in 91% of cases (96% in females and 83% in males; p < 0.001). HPV16 was by far the most prevalent genotype (75%), followed by HPV18, HPV52, HPV33, and HPV51 (4–6%). HPV16/18 alone or in association were found in 78% of all cases. HIV‐positive cases had a higher proportion of multiple HPV infection than HIV‐negative cases and a slightly different HPV type distribution with an under‐representation of HPV16 and an over‐representation of other types. Our results indicate that anal cancer rarely occurs in the absence of HPV and emphasize the predominant role of HPV16. The potential benefit of HPV vaccine on the occurrence of anal cancer should be further evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Amplification of Genital Human Papillomaviruses
Gravitt, P. E., Peyton, C. L., Alessi, T. Q., Wheeler, C. M., Coutlée, F., Hildesheim, A., Schiffman, M. H., Scott, D. R., & Apple, R. J. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.357-361.2000 · Cited by 1,137
Cited by
Alemany, L., Saunier, M., Alvarado-Cabrero, I., Quirós, B., Salmeron, J., Shin, H.-R., Pirog, E. C., Guimerà, N., Hernandez-Suarez, G., Felix, A., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.28963 · Cited by 388
Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
Riethmuller, D., Jacquard, A.-C., Lacau St Guily, J., Aubin, F., Carcopino, X., Pradat, P., Dahlab, A., & Prétet, J.-L. (2015) · BMC Public Health · doi:10.1186/s12889-015-1779-1 · Cited by 61
Self-citation
Metadata
- Authors
- Abramowitz, L., Jacquard, A., Jaroud, F., Haesebaert, J., Siproudhis, L., Pradat, P., Aynaud, O., Leocmach, Y., Soubeyrand, B., Dachez, R., Riethmuller, D., Mougin, C., Pretet, J., & Denis, F.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2010-11-09
- Volume
- 129
- Issue
- 2
- Pages
- 433-439
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1969100627
- Cited by
- 175
- References
- 1
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study. https://app.cochat.ai/papers/10.1002/ijc.25671
- The paper
- Abramowitz, L., Jacquard, A., Jaroud, F., Haesebaert, J., Siproudhis, L., Pradat, P., Aynaud, O., Leocmach, Y., Soubeyrand, B., Dachez, R., Riethmuller, D., Mougin, C., Pretet, J., & Denis, F. (2011). Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study. International Journal of Cancer. https://doi.org/10.1002/ijc.25671
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.